Huntington Disease: all 290 studies
Page 3 of 3. Open to participants first (49), then studies with results posted, then the rest; newest registration first within each.
- Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD StudyStatus unknownNCT02563418Not applicable
- Functional Imaging of Social Cognition in Premanifest Huntington's DiseaseStatus unknownNCT02551705Not applicable
- Social Cognition in Huntington's Disease: Cognitive Study and Functional and Morphological ImagingCompletedNCT02550275Not applicable
- Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)CompletedNCT02535884Not applicable
- A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)Status unknownNCT02509793Phase 4
- A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of PepiCompletedNCT02481674Phase 2
- A Pilot Evaluation of Mindfulness-based Cognitive Therapy for People With Huntington's DiseaseCompletedNCT02464293Not applicable
- A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's DiseaseCompletedNCT02453061Phase 2
- Resveratrol and Huntington DiseaseCompletedNCT02336633Not applicable
- Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's DiseaseCompletedNCT02268617Not applicable
- PINS Stimulator System for Deep Brain Stimulation in Huntington's DiseaseStatus unknownNCT02263430Not applicable
- ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement DisordersActive, not recruitingNCT02252380Not applicable
- Behavioural Problems in Huntington Disease : Analysis and Enhancement of Caregiver and Patient ExperienceTerminatedNCT02218567Not applicable
- Brain Stimulation in Movement DisordersCompletedNCT02216474Not applicable
- Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male VolunteersCompletedNCT02208934Phase 1
- Assessment of the Psychological, Cognitive and Social Resources of Applicants for Huntington's Disease and Presymptomatic Genetic TestingCompletedNCT02134561Not applicable
- Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)Status unknownNCT02101957Phase 2/3
- Safety and Efficacy of OMS643762 in Subjects With Huntington's DiseaseTerminatedNCT02074410Phase 2
- [PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET.CompletedNCT02061722Early Phase 1
- A Pre-Cellular Therapy Observational Study in Early Huntington's DiseaseCompletedNCT01937923
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Evaluating the Relationship of Morphine Consumption and Pain-related Molecules in Hepatic Surgical PatientsCompletedNCT01919034
- Apathy Cure Through Bupropion in Huntington's DiseaseCompletedNCT01914965Phase 2
- Accelerated Diffusion MRI for Diagnosis of Hungtington DiseaseCompletedNCT01884181
- Exercise Effects in Huntington's DiseaseCompletedNCT01879267Not applicable
- Child to Adult Neurodevelopment in Gene Expanded Huntington's DiseaseCompletedNCT01860339
- Dance and Huntington DiseaseCompletedNCT01842919Not applicable
- Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.Status unknownNCT01834053Phase 1/2
- Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington DiseaseCompletedNCT01696708Not applicable
- Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's DiseaseCompletedNCT01602900Phase 1
- A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker DiscoveryCompletedNCT01592552
- REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)CompletedNCT01590602
- REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)CompletedNCT01590589
- A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278CompletedNCT01573819Phase 1
- Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)Status unknownNCT01554033
- Escalating Dose Study in Healthy Volunteers With SEN0014196CompletedNCT01521832Phase 1
- A Phase II Safety and Tolerability Study With SEN0014196CompletedNCT01521585Phase 2
- Neuroprotection by Cannabinoids in Huntington's DiseaseCompletedNCT01502046Phase 2
- A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington DiseaseCompletedNCT01485965Phase 1
- An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196CompletedNCT01485952Phase 1
- A Trial of Memantine as Symptomatic Treatment for Early Huntington DiseaseCompletedNCT01458470Phase 2
- Study of Biomarkers That Predict the Evolution of Huntington's DiseaseStatus unknownNCT01412125
- Premanifest Huntington's Disease Extension Study II: Creatine Safety & TolerabilityCompletedNCT01411163Phase 2
- Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension StudyCompletedNCT01411150Phase 2
- 31P-MRS and Huntington DiseaseCompletedNCT01359774Not applicable
- Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)CompletedNCT01357681Phase 2
- Assessment of Social-emotional Functioning in Neurological DiseasesCompletedNCT01339130Not applicable
- Cognitive Assessment Battery (CAB) Beta StudyCompletedNCT01290861
- An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington DiseaseTerminatedNCT01085266Phase 3
- Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing ChoreaTerminatedNCT01019473Phase 2
- A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The SkinCompletedNCT00990613Phase 1
- A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)CompletedNCT00988624Phase 1
- Bioavailability of Ubiquinol in Huntington DiseaseCompletedNCT00980694Phase 1
- Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.CompletedNCT00970229Phase 1
- A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 MetabolizersCompletedNCT00931073Phase 1
- A Safety and Efficacy Study of Dimebon in Patients With Huntington DiseaseCompletedNCT00920946Phase 3
- Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With RamelteonWithdrawnNCT00907595Not applicable
- Deep Brain Stimulation of the Globus Pallidus in Huntington's DiseaseCompletedNCT00902889Phase 1
- A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric ConditionsCompletedNCT00870974Phase 1
- Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy SubjectsCompletedNCT00831506Phase 1
- A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy SubjectsCompletedNCT00827034Phase 1
- A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy SubjectsCompletedNCT00825084Phase 1
- A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal FunctionCompletedNCT00824590Phase 1
- A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of DextromethorphanCompletedNCT00788047Phase 1
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)TerminatedNCT00712426Phase 3
- Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD)Status unknownNCT00675077Phase 1
- Memory Disorders RegistryCompletedNCT00654563
- Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and TiaprideCompletedNCT00632645Phase 3
- Creatine Safety and Tolerability in Premanifest HD: PRECRESTCompletedNCT00592995Phase 2
- Making Sense of a Positive Genetic Test Result for Huntington DiseaseCompletedNCT00539747
- Ursodiol in Huntington's DiseaseStatus unknownNCT00514774Phase 1
- A Study of the Novel Drug Dimebon in Patients With Huntington's DiseaseCompletedNCT00497159Phase 2
- Individuals Patterns of Disclosure About Huntington s Disease (HD) and the Association With Adaptation to HDCompletedNCT00491842
- Research of Biomarkers in Parkinson DiseaseCompletedNCT00465790
- Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's DiseaseCompletedNCT00387270Phase 1/2
- Cooperative Huntington's Observational Research TrialStatus unknownNCT00313495
- Riluzole in Huntington's DiseaseCompletedNCT00277602Phase 3
- Efficacy and Safety of Tetrabenazine in ChoreaCompletedNCT00219804Phase 3
- Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)CompletedNCT00212316Phase 2
- MIG-HD: Multicentric Intracerebral Grafting in Huntington's DiseaseCompletedNCT00190450Phase 2
- Effects of Music Therapy on Huntington's DiseaseCompletedNCT00178360Phase 1
- TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's DiseaseCompletedNCT00146211Phase 3
- Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's DiseaseCompletedNCT00095355Phase 2
- Family Health After Predictive Huntington Disease (HD) TestingCompletedNCT00075140
- Prospective Huntington At Risk Observational StudyCompletedNCT00052143
- Neurobiological Predictors of Huntington's Disease (PREDICT-HD)Active, not recruitingNCT00051324
- Minocycline in Patients With Huntington's DiseaseCompletedNCT00029874Phase 1/2
- Creatine Therapy for Huntington's DiseaseCompletedNCT00026988Phase 1/2
- Long-Term Study of Cerebral Glucose Metabolism in Huntington's DiseaseCompletedNCT00004753
- Treatment of Huntington's Chorea With AmantadineCompletedNCT00001930Phase 2